The Impact of Cannabidiol on the Induction of Isoflurane Anesthesia and Recovery in Wistar Rats

Cannabis Cannabinoid Res. 2022 Jun;7(3):289-293. doi: 10.1089/can.2021.0014. Epub 2021 May 11.

Abstract

Background: Beside others, neuroinhibitory and sedative effects of CBD were documented. Aim and Methods: The aim of the study was to assess the dose-related effects of CBD premedication on the course of isoflurane anesthesia. Wistar rats were pretreated with different doses of CBD 1 h before isoflurane anesthesia. In the pretreatment, animals were given CBD at doses of 100, 20, 10, or 2 mg kg-1. Before the fifth (control) anesthesia, the animals were given only mid-chain triglyceride oil, which served as a solvent in the CBD formulation. The induction time was determined, and on awakening, the time to appearance of the flexion reflex and the recovery from anesthesia were determined. Results: Statistical analysis showed a significantly shorter induction time if animals were pretreated with 20 mg kg-1 CBD. In addition, pretreatment with 100 mg kg-1 CBD resulted in a prolonged induction time, while on awakening, delayed appearance of reflexes and prolonged recovery from anesthesia compared to pretreatment with 20 mg kg-1 CBD were observed. Conclusions: The results indicate that the influence of CBD on the course of isoflurane anesthesia depends on the dose and can reduce the induction time. Although this study was performed in laboratory rats, in clinical practice, these data should be considered when CBD-treated patients undergo isoflurane anesthesia.

Keywords: anesthesia; cannabidiol; induction; isoflurane; recovery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthesia Recovery Period
  • Anesthesia*
  • Animals
  • Cannabidiol* / pharmacology
  • Humans
  • Isoflurane* / pharmacology
  • Rats
  • Rats, Wistar

Substances

  • Cannabidiol
  • Isoflurane